Skip to main content

Published locations for IV secukinumab, alternative to self-injections, reaches primary endpoints in PsA, axSpA

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. IV secukinumab, alternative to self-injections, reaches primary endpoints in PsA, axSpA

User login

  • Reset your password
  • /content/iv-secukinumab-alternative-self-injections-reaches-primary-endpoints-psa-axspa
  • /edermatologynews/article/266636/psoriatic-arthritis/iv-secukinumab-alternative-self-injections
  • /familypracticenews/article/266636/psoriatic-arthritis/iv-secukinumab-alternative-self-injections
  • /internalmedicinenews/article/266636/psoriatic-arthritis/iv-secukinumab-alternative-self-injections
  • /rheumatologynews/article/266636/psoriatic-arthritis/iv-secukinumab-alternative-self-injections
  • /rheumatology/article/266636/psoriatic-arthritis/iv-secukinumab-alternative-self-injections-reaches
  • /internalmedicine/article/266636/psoriatic-arthritis/iv-secukinumab-alternative-self-injections
  • /dermatology/article/266636/psoriatic-arthritis/iv-secukinumab-alternative-self-injections-reaches
  • /familymedicine/article/266636/psoriatic-arthritis/iv-secukinumab-alternative-self-injections-reaches